Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women
Na minha lista:
Wright, T.E., ET AL., Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduction Journal, Vol. 9, no. 5 (2012), p. 1-10.
Ref.
184119
Localização:
SIIS R.1830 Archivo
Palabras clave:
Anfetaminas, Drogas de síntesis, Drogodependencias, Embarazo, Evaluación de servicios, Mujer, Reducción de daños, Tabaco, EE.UU.
Anfetaminas, Drogas de síntesis, Drogodependencias, Embarazo, Evaluación de servicios, Mujer, Reducción de daños, Tabaco, EE.UU.
Registos relacionados: Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women
- A GLASS HALF FULL? HARM REDUCTION AMONG PREGNANT WOMEN WHO USE COCAINE
- Examining barriers to harm reduction and child welfare services for pregnant women and mothers who use substances using a stigma action framework
- METHAMPHETAMINE USE AMONG PREGNANT WOMEN
- Examining barriers to harm reduction and child welfare services for pregnant women and mothers who use substances using a stigma action framework
- ASSESSING ENVIRONMENTAL PREVENTION STRATEGIES FOR REDUCING THE PREVALENCE AND ASSOCIATED HARMS OF METHAMPHETAMINE USE
- A FOUR PILLARS APPROACH TO METHAMPHETAMINE: POLICIES FOR EFFECTIVE DRUG PREVENTION, TREATMENT, POLICING AND HARM REDUCTION